GALECTIN THERAPEUTICS INC — Director's Dealing 2017

May 1, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2017-04-23

Reporting Person: Uihlein Richard E (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2509909	Direct
Common Stock	20000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock Purchase Warrant (right to buy)	$5.00	2023-12-22	Common Stock (1466204)		Direct
Series C Super Dividend Convertible Preferred Stock	$6.00		Common Stock (83333)		Direct

Footnotes

F1: The reporting person is president and director of Ed Uihein Family Foundation, a not-for-profit corporation. The reportion person has no pecuniary interest in the shares, however, he shares voting and dispositive power over the shares and, therefore, remains the beneficial owner of the shares solely for purposes of Section 13(d) of the Securities Exchange Act of 1934.

F2: The conversion rights for the Series C Super Dividend Convertible Preferred Stock do not expire.